Literature DB >> 33875814

Autologous stem cell transplant for patients with multiple myeloma between ages 75 and 78.

Mark A Fiala1, Justin King2, Daniel Feinberg2, Scott R Goldsmith2, Mark A Schroeder2, Armin Ghobadi2, Keith E Stockerl-Goldstein2, Ravi Vij2, Tanya M Wildes2.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33875814     DOI: 10.1038/s41409-021-01295-w

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.174


× No keyword cloud information.
  9 in total

1.  Autologous Hematopoietic Cell Transplantation in Patients With Multiple Myeloma: Effect of Age.

Authors:  Binod Dhakal; Ariel Nelson; Guru Subramanian Guru Murthy; Raphael Fraser; Daniel Eastwood; Mehdi Hamadani; Marcello Pasquini; Anita D'Souza; Parameswaran Hari
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2016-11-25

2.  Drug Combinations with Transplantation for Myeloma.

Authors:  Michel Attal; Paul G Richardson; Philippe Moreau
Journal:  N Engl J Med       Date:  2017-07-06       Impact factor: 91.245

3.  Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma.

Authors:  Thierry Facon; Shaji Kumar; Torben Plesner; Robert Z Orlowski; Philippe Moreau; Nizar Bahlis; Supratik Basu; Hareth Nahi; Cyrille Hulin; Hang Quach; Hartmut Goldschmidt; Michael O'Dwyer; Aurore Perrot; Christopher P Venner; Katja Weisel; Joseph R Mace; Noopur Raje; Michel Attal; Mourad Tiab; Margaret Macro; Laurent Frenzel; Xavier Leleu; Tahamtan Ahmadi; Christopher Chiu; Jianping Wang; Rian Van Rampelbergh; Clarissa M Uhlar; Rachel Kobos; Ming Qi; Saad Z Usmani
Journal:  N Engl J Med       Date:  2019-05-30       Impact factor: 91.245

4.  Autologous transplantation and maintenance therapy in multiple myeloma.

Authors:  Antonio Palumbo; Federica Cavallo; Francesca Gay; Francesco Di Raimondo; Dina Ben Yehuda; Maria Teresa Petrucci; Sara Pezzatti; Tommaso Caravita; Chiara Cerrato; Elena Ribakovsky; Mariella Genuardi; Anna Cafro; Magda Marcatti; Lucio Catalano; Massimo Offidani; Angelo Michele Carella; Elena Zamagni; Francesca Patriarca; Pellegrino Musto; Andrea Evangelista; Giovannino Ciccone; Paola Omedé; Claudia Crippa; Paolo Corradini; Arnon Nagler; Mario Boccadoro; Michele Cavo
Journal:  N Engl J Med       Date:  2014-09-04       Impact factor: 91.245

5.  Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma.

Authors:  Michel Attal; Valerie Lauwers-Cances; Cyrille Hulin; Xavier Leleu; Denis Caillot; Martine Escoffre; Bertrand Arnulf; Margaret Macro; Karim Belhadj; Laurent Garderet; Murielle Roussel; Catherine Payen; Claire Mathiot; Jean P Fermand; Nathalie Meuleman; Sandrine Rollet; Michelle E Maglio; Andrea A Zeytoonjian; Edie A Weller; Nikhil Munshi; Kenneth C Anderson; Paul G Richardson; Thierry Facon; Hervé Avet-Loiseau; Jean-Luc Harousseau; Philippe Moreau
Journal:  N Engl J Med       Date:  2017-04-06       Impact factor: 91.245

6.  A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome.

Authors:  M Attal; J L Harousseau; A M Stoppa; J J Sotto; J G Fuzibet; J F Rossi; P Casassus; H Maisonneuve; T Facon; N Ifrah; C Payen; R Bataille
Journal:  N Engl J Med       Date:  1996-07-11       Impact factor: 91.245

7.  Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.

Authors:  Francesca Gay; Stefania Oliva; Maria Teresa Petrucci; Concetta Conticello; Lucio Catalano; Paolo Corradini; Agostina Siniscalchi; Valeria Magarotto; Luděk Pour; Angelo Carella; Alessandra Malfitano; Daniela Petrò; Andrea Evangelista; Stefano Spada; Norbert Pescosta; Paola Omedè; Philip Campbell; Anna Marina Liberati; Massimo Offidani; Roberto Ria; Stefano Pulini; Francesca Patriarca; Roman Hajek; Andrew Spencer; Mario Boccadoro; Antonio Palumbo
Journal:  Lancet Oncol       Date:  2015-11-17       Impact factor: 41.316

8.  Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma.

Authors:  Pashna N Munshi; David Vesole; Artur Jurczyszyn; Jan Maciej Zaucha; Andrew St Martin; Omar Davila; Vaibhav Agrawal; Sherif M Badawy; Minoo Battiwalla; Saurabh Chhabra; Edward Copelan; Mohamed A Kharfan-Dabaja; Nosha Farhadfar; Siddhartha Ganguly; Shahrukh Hashmi; Maxwell M Krem; Hillard M Lazarus; Ehsan Malek; Kenneth Meehan; Hemant S Murthy; Taiga Nishihori; Rebecca L Olin; Richard F Olsson; Jeffrey Schriber; Sachiko Seo; Gunjan Shah; Melhem Solh; Jason Tay; Shaji Kumar; Muzaffar H Qazilbash; Nina Shah; Parameswaran N Hari; Anita D'Souza
Journal:  Cancer       Date:  2020-09-23       Impact factor: 6.860

9.  Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial.

Authors:  J R Jones; D A Cairns; W M Gregory; C Collett; C Pawlyn; R Sigsworth; A Striha; R Henderson; M F Kaiser; M Jenner; G Cook; N H Russell; C Williams; G Pratt; B Kishore; J Lindsay; M T Drayson; F E Davies; K D Boyd; R G Owen; G H Jackson; G J Morgan
Journal:  Blood Cancer J       Date:  2016-12-09       Impact factor: 11.037

  9 in total
  1 in total

Review 1.  Genome Instability in Multiple Myeloma: Facts and Factors.

Authors:  Anna Y Aksenova; Anna S Zhuk; Artem G Lada; Irina V Zotova; Elena I Stepchenkova; Ivan I Kostroma; Sergey V Gritsaev; Youri I Pavlov
Journal:  Cancers (Basel)       Date:  2021-11-26       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.